1. Home
  2. GLP vs MNKD Comparison

GLP vs MNKD Comparison

Compare GLP & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$47.40

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.82

Market Cap

793.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
MNKD
Founded
2005
1991
Country
United States
United States
Employees
4700
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
793.6M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
GLP
MNKD
Price
$47.40
$2.82
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$46.00
$8.69
AVG Volume (30 Days)
30.8K
3.3M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
6.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
$348,966,000.00
Revenue This Year
$64.13
$35.81
Revenue Next Year
$11.74
$11.89
P/E Ratio
$23.28
$137.75
Revenue Growth
N/A
22.23
52 Week Low
$39.58
$2.23
52 Week High
$56.51
$6.51

Technical Indicators

Market Signals
Indicator
GLP
MNKD
Relative Strength Index (RSI) 61.40 52.60
Support Level $45.78 $2.52
Resistance Level $48.48 $2.98
Average True Range (ATR) 1.49 0.13
MACD 0.28 0.05
Stochastic Oscillator 100.00 67.06

Price Performance

Historical Comparison
GLP
MNKD

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: